Vanguard Group Inc Ptc Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,178,822 shares of PTCT stock, worth $455 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,178,822
Previous 9,125,134
0.59%
Holding current value
$455 Million
Previous $339 Million
22.39%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding PTCT
# of Institutions
264Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Black Rock Inc. New York, NY7.77MShares$385 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$366 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$316 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$163 Million0.24% of portfolio
-
Camber Capital Management LP Boston, MA3.2MShares$158 Million3.34% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.54B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...